Hemochromatosis is an inherited disease in which the body absorbs too much iron from the diet. Hemochromatosis is one of the most common genetic diseases in Canada affecting 1 in 327 Canadians. Normally, only enough iron to meet the body’s daily requirements is absorbed; the remainder is usually excreted through the bowels. In hemochromatosis, however, iron continues to be absorbed and stored in different organs and tissues long after body needs are met.
The liver is the first organ to store iron and when its storage capacity is exhausted, the iron continues to accumulate in the heart, the pituitary gland and elsewhere in the body. If untreated, damage to the liver, heart, and pancreas may eventually lead to death.
Hemochromatosis is hereditary. In order to have the disease, a patient must have inherited two defective genes, one from each parent. Siblings of an affected individual have a 25 percent chance of getting this disease. Children are less likely to be affected since the other parent must be a carrier of a hemochromatosis gene.
The liver begins to retain iron at birth, but it may take 20 to 30 years before symptoms manifest themselves. In the early stages of hemochromatosis, there may be no signs, but when symptoms begin to appear, they include:
- swelling in the joints (arthritis), particularly in the knuckles of the middle and index fingers
In the later stages of the disease, symptoms include:
- abdominal pain or tenderness
- yellowing of the skin and eyes (jaundice)
- distention of the abdomen (ascites)
- bleeding from dilated veins in the esophagus (variceal bleeding)
- development of diabetes
- the skin may have a bronze or grey colour
- excessive hunger and thirst
- frequent urination
How does hemochromatosis affect other organs?
Iron accumulation in the heart muscle may produce irregular heart rhythm and heart failure causing shortness of breath and swelling of the ankles.
When iron is deposited in the pituitary gland, it can lead to sexual dysfunction, loss of libido and impotence in men, and menstrual irregularities in women.
Blood tests to measure the iron level in the blood and the total amount of iron deposited in the tissues are done to detect hemochromatosis. The most common tests are the transferrin saturation and serum ferritin.
A new development is a genetic test for hemochromatosis. The test is usually done on a blood sample in a provincial regional lab specializing in DNA testing. The C282Y mutation of the hemochromatosis gene is present in greater than 90 percent of typical hemochromatosis patients.
Additional diagnostic procedures may include a liver biopsy to determine if liver damage is present and to assess the amount of iron stored there. The genetic test has alleviated the need for liver biopsy in many young patients with hemochromatosis.
Who should be screened?
As soon as a person is diagnosed as having hemochromatosis, the spouse, brothers, sisters, and children over the age of 18 should be checked. Screening is of greatest importance for siblings since they have a 25 percent chance of inheriting the defective genes from their parents.
Genetic screening has allowed for the diagnosis at birth before iron overload has developed. It is probably ideal to test for hemochromatosis within families in teenagers rather than in very young children.
The primary aim of treatment is to reduce the amount of iron stored in the body. This is accomplished by a procedure known as venesection or phlebotomy (bloodletting). It is usually done on a weekly basis and is similar to making a blood donation. Since the red blood cells contain iron, essential for transporting oxygen and nutrients to the tissues, the body will draw on the accumulated iron to replace the lost red blood cells.
Treatment may take months, or even up to two or three years, depending on the amount of iron that has accumulated. Once the excess iron has been removed by blood-letting, the person must continue to have the amount of body iron monitored annually.
Is a special diet necessary?
No. However, iron supplements or multi-vitamins and mineral preparations containing iron should not be used. Also, vitamin C, which enhances the absorption of iron when consumed with food, should be avoided or only taken four hours before or after a meal. The consumption of excess alcohol should be avoided as it also enhances the absorption of iron.
Can tissue damage be reversed?
Injury to the liver is reversible provided treatment is started before cirrhosis (scarring of the liver) has developed. However, there is an increased risk of liver cancer in people with hemochromatosis who have cirrhosis.
The early detection and treatment of hemochromatosis are crucial in preventing the complications of this potentially fatal disease.
National Help Line:
This support resource gives you and your loved one somewhere to turn for answers after diagnosis, helps you understand your disease, and provides you with the resources you need. You can call 1 (800) 563-5483 Monday to Friday from 9 AM to 5 PM EST.
The Peer Support Network:
This is a national network of people living with liver disease that have offered to share their experiences with others. It was developed by the Canadian Liver Foundation as a means to link Canadians like you who have a family member who has liver disease, who care for someone who suffers from liver disease, or who have been diagnosed with a liver disease, to talk about your concerns with a peer in a similar situation.
If you would like to be connected with a peer supporter in your area, or would like to join the peer support network, please call the National Help Line at 1 (800) 563-5483 Monday to Friday from 9 AM to 5 PM EST or email us.
Help us help you!
If you are not satisfied with the information you just read or any information on our website, please take a moment to send us your comments and suggestions on the type of content you would like to find on liver.ca. Please include the page you are commenting about in the subject line of your email.